171 related articles for article (PubMed ID: 19815369)
1. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].
Satger B; Blaise S; Fontaine M; Yver J; Allenet B; Baudrant M; Pernod G; Bosson JL
Presse Med; 2009 Dec; 38(12):1780-7. PubMed ID: 19815369
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Ansell J; Hirsh J; Hylek E; Jacobson A; Crowther M; Palareti G
Chest; 2008 Jun; 133(6 Suppl):160S-198S. PubMed ID: 18574265
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K antagonists and emergencies.
Lapostolle F; Siguret V; Martin AC; Pailleret C; Vigué B; Zerbib Y; Tazarourte K
Eur J Emerg Med; 2018 Dec; 25(6):378-386. PubMed ID: 29462053
[TBL] [Abstract][Full Text] [Related]
5. [What is the current use of vitamin K antagonists in the elderly?].
Vidal JS; Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
[TBL] [Abstract][Full Text] [Related]
6. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic education of elderly patients under antivitamin - K treatment: evaluation of the program after 5 years].
Thiriat N; Peyron I; Bernard-Charrière S; Monti A; Pariel S; Pautas E
J Pharm Belg; 2014 Sep; (3):30-7. PubMed ID: 25226761
[TBL] [Abstract][Full Text] [Related]
8. [Novel oral anticoagulants and atrial fibrillation in the elderly].
Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):34-40. PubMed ID: 24463062
[TBL] [Abstract][Full Text] [Related]
9. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
Beyer-Westendorf J; Ageno W
Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
[TBL] [Abstract][Full Text] [Related]
11. Optimizing quality care for the oral vitamin K antagonists (VKAs).
Pengo V; Denas G
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):332-338. PubMed ID: 30504329
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of an education program for patients taking oral anticoagulants: Experience of the GRANTED network in Isère].
Blaise S; Satger B; Fontaine M; Yver J; Rastel D; Toffin L; Seinturier C; Ramos M; Bosson JL; Pernod G;
J Mal Vasc; 2009 Nov; 34(5):346-53. PubMed ID: 19782487
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
14. [Management of vitamin K antagonists in the elderly].
Belleville T; Pautas É; Gaussem P; Siguret V
Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
[TBL] [Abstract][Full Text] [Related]
15. Reversing vitamin K antagonists: making the old new again.
Eichinger S
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):605-611. PubMed ID: 27913535
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
17. Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.
Pautas E; Gouin-Thibault I; Debray M; Gaussem P; Siguret V
Drugs Aging; 2006; 23(1):13-25. PubMed ID: 16492066
[TBL] [Abstract][Full Text] [Related]
18. New oral anticoagulants in thrombotic antiphospholipid syndrome.
Chighizola CB; Moia M; Meroni PL
Lupus; 2014 Oct; 23(12):1279-82. PubMed ID: 25228726
[TBL] [Abstract][Full Text] [Related]
19. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
Phillips KW; Ansell J
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K antagonists and risk of subdural hematoma: meta-analysis of randomized clinical trials.
Connolly BJ; Pearce LA; Hart RG
Stroke; 2014 Jun; 45(6):1672-8. PubMed ID: 24876259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
